Objectives. Discusscommon causes for nausea and vomiting. Identify the areas of the body and receptors involved that stimulate nausea and vomiting

Similar documents
Objectives. Mechanism-Based Therapy. The Approach to Nausea, Vomiting, and Pain at The End of Life

Guidelines for the Management of. Nausea and Vomiting in Cancer Patients

Guidelines for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in Adults

DIABETIC ENTEROPATHY: TWO. Gary L. Cornette, D.O., F.A.C.O.I Medical Director Gastroenterology

Chemotherapy Induced Nausea & Vomiting

Nausea and Vomiting. Understanding nausea and vomiting. What causes nausea and vomiting in people with cancer?

Nausea & Vomiting Palliative Care Strategies. Chip Baker MS, NP-C, ACHPN January 2012

11. CANCER PAIN AND PALLIATION. Jennifer Reifel, M.D.

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Your A-Z of coping with nausea and vomiting A guide for patients and their carers. We care, we discover, we teach

Optimizing Care for the Individual with Cancer: Counseling Patients and Families on Cancer Treatment

Pain and Symptom Management in Pancreatic Cancer

Coping With Nausea and Vomiting From Chemotherapy

Delayed emesis: moderately emetogenic chemotherapy

The N Factor: Prevention & Treatment of Chemotherapy-Induced Nausea & Vomiting

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

PALLIATIVE PAIN AND SYMPTOM MANAGEMENT POCKET REFERENCE GUIDE

Texas Medicaid/CHIP Vendor Drug Program Drug Utilization Criteria For Outpatient Use Guidelines

Animportant goal of pain management is to

Pain and Symptom Management in the Pancreatic Cancer Patient. Objectives:

1. According to recent US national estimates, which of the following substances is associated

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth

Crisis Management in Hospice Patients

EPEC. Common Physical Symptoms. Module 10. Participant s Handbook. Education for Physicians on End-of-life Care

Postoperative nausea and vomiting (PONV) is a. Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting

Pain management. The WHO analgesic ladder

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

Anticipating And Preparing For Predictable Clinical Challenges In The Medical Care Of The Terminally Ill Person Wishing To Die At Home.

April 12, 2013 Mandy C. Leonard, Pharm.D., BCPS Department of Pharmacy

NURSING RESEARCH IMPORTANT POINTS COMPONENTS COMPONENTS. Proposed timeline Consent/ protection of human

D( desired ) Q( quantity) X ( amount ) H( have)

Benzodiazepines: A Model for Central Nervous System (CNS) Depressants

Treatment of gastroparesis: a multidisciplinary clinical review

Associate Professor, Department of Anaesthesia, Government Medical College, Telangana. 3


Postoperative nausea and vomiting (PONV) is

Headaches in Children

Antiemetic Guidelines for Adult Patients Receiving Chemotherapy and Radiotherapy

Objectives PREVENTION AND TREATMENT OF CINV & VTE IN ONCOLOGY PATIENTS. Case 1. Case 1. Case 2 2/1/2015

Medications Used in the Treatment of Addiction Developed by Randall Webber, MPH. Alcohol Withdrawal

Management of Constipation in Adults

Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program

END OF LIFE MEDICINES INFORMATION PACK

Applying the Principles of Antiemetic Therapy to the Management of CINV: A Case-study Approach

Treating Severe Migraine Headaches in the Emergency Room A Review of the Research for Adults

PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY

Integration and Coordination of the Human Body. Nervous System

Antidiarrheal Drugs. Causes of Diarrhea. Antidiarrheal Drugs

Headaches. This chapter will discuss:

Emergency management of patients with Parkinson s

Key Points. Autonomic Nervous System Drugs. Autonomic effects Sympathetic. Drugs can modify ANS activity by: Autonomic Nervous System

SUMMARY OF RECOMMENDATIONS

Opioid Analgesics. Week 19

Postoperative nausea and vomiting, defined as nausea

PRACTICE Guidelines are systematically developed recommendations

A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS

CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE

Nurses Self Paced Learning Module on Pain Management

Chronic Nausea & Vomiting

Published Ahead of Print on September 26, 2011 as /JCO J Clin Oncol by American Society of Clinical Oncology

Symptom Control and Caring for the Dying Patient: Palliative Care Guidelines 4th Edition

Postoperative nausea and vomiting (PONV) Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea

N-methyl-D-aspartate (NMDA) Receptor Antagonist Memantine (CWM TAF ONLY)

HOW TO CITE THIS ARTICLE:

Drug addiction. These factors increase the likelihood of your having an addiction to a legal or an illegal drug:

Pain is a symptom people associate with a malignant illness and is common in non malignant disease.

Community Pharmacists in NHS Rotherham

Acute management of Parkinson s

North of England Cancer Network. Palliative and end of life care guidelines for cancer and non-cancer patients

THE PALLIATIVE CARE HANDBOOK. Advice on clinical management

BENZTROP 2 mg tablets are round, flat-faced, cross-scored on one side and embossed PMS- 2 on the other side.

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Appendix 4: Guidelines for Prescribing and Administering Drugs:

Olanzapine Lab Tests. olanzapine controlled substance. olanzapine oral. olanzapine j code. olanzapine level. olanzapine treats what

Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management of Acute Attacks

Review of Pharmacological Pain Management

Emergency and inpatient treatment of migraine: An American Headache Society

Gastrointestinal problems in children with metabolic disorders

NAUSEA AND VOMITING. Ryan F. Porter, M.D. and C. Prakash Gyawali, M.D., MRCP Division of Gastroenterology Washington University St.

Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment

Downers/Depressants (pages 40-50)

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room

Union EMS Local Formulary July 18, 2014

Pharmacotherapy of BPSD. Pharmacological interventions. Anti-dementia drugs. Abhilash K. Desai MD Medical Director Alzheimer s Center of Excellence

Pediatric Pain and Symptom Management Guidelines

Stimulants Notes. What is heroin?

Serotonin receptors antagonists as antiemetics

Table of Contents. Neurotra nsmission F act Sh eet Page 2. Neurotransmission Scavenger Hunt Page 4. Brain Parts Fact Sheet Page 6

MASCC/ESMO Antiemetic Guideline 2013

AQI QCDR Measure Specification

Nausea is a frequent and debilitating side-effect of cancer. Protein and Ginger for the Treatment of Chemotherapy-Induced Delayed Nausea

Normal Aging versus Alzheimer Disease Drugs to treat the symptoms that are not due to old age. Leah Wright, HBSc. BSP student June 2006

5-Fluorouracil & Radiotherapy for Adjuvant Oesophageal or Gastric Cancer (Modified Macdonald Protocol)

AANA Journal Course 1

Olanzapine Maximum Dose

Olanzapine Uses. olanzapine generic name. olanzapine uptodate. olanzapine other names. olanzapine vomiting. olanzapine leukopenia.

Olanzapine Generic Availability

Olanzapine Renal Dosing

Transcription:

Objectives Discusscommon causes for nausea and vomiting Identify the areas of the body and receptors involved that stimulate nausea and vomiting Select medications to help control nausea and vomiting Differentiate approaches to managing nausea and vomiting using the above

Incidence Nausea: 50 60% Vomiting: 30%

Causes Metastases Mechanical Obstruction Meningeal irritation Motility Movement Metabolic Mental anxiety Microbial Medications

Neurophysiology of Nausea/Vomiting Cerebral Cortex Chemoreceptor Trigger Zone Vestibular Centre Vagus Vomiting Centre GI Tract Emesis C. Woelk

Chemoreceptor Trigger Zone Cerebral High CNS Sights, Smells Memories Vestibular Opioids Cerebellar Tumor Increased Intracranial Press Primary or Met. Tumor G. Michael Downing Integrative Vomiting Centre (IVC) Toxic Ca Emetogenic Infection Radiation Drugs Chemotherapy Opioids Digoxin, etc Biochemical Uremia Hypercalcemia GI Tract Vagal Distension Over eating Gastric Stasis Extrinsic Press. Obstruction High, mid, low Constipation Chemical Irritants Blood, drugs

Receptors Acetylcholine (AchM) Histamine (H1) Dopamine (D2) Serotonin (5 HT3) GABA THC Neurokinin (NK)

Vestibular (H1 AchM) Movements CTZ Opioids

Chemoreceptor Trigger Zone (5 HT3 D2 NK and more) Toxins Metabolites Tumour Factors Vestibular System Drugs Vagus

Cerebral Cortex (GABA 5 HT3) Meningeal irritation ICP Ð Na+, ÏCa2+ Opioids Pain Past experiences Anxiety/Fear Tastes/smells

Vagus (5 HT3 NK AchM) Mechanoreptors Chemoreceptors Hepatic Chemoreceptors

GI Tract (D2 5 HT3 AchM) Drugs Obstruction Other Medical Conditions

Neurophysiology of Nausea / Vomiting Chemoreceptor Trigger Zone Cerebral Cortex GABA 5-HT3 5-HT3 D2 NK1 More Vomiting Centre Vagus 5-HT3 NK1?AchM GI Tract D2 5-HT3 Achm Achm H1 5-HT3 NK1 More Vestibular Centre H1 Achm Emesis C. Woelk

Chemoreceptor Trigger Zone Cerebral High CNS Sights, Smells Memories Vestibular Opioids Cerebellar Tumor Increased Intracranial Press Primary or Met. Tumor G. Michael Downing Integrative Vomiting Centre (IVC) Toxic Ca Emetogenic Infection Radiation Drugs Chemotherapy Opioids Digoxin, etc Biochemical Uremia Hypercalcemia GI Tract Vagal Distension Over eating Gastric Stasis Extrinsic Press. Obstruction High, mid, low Constipation Chemical Irritants Blood, drugs

Medications Dopamine antagonists H1 antagonists (antihistaminics) Serotonin antagonists Antimuscarinic (anticholinergics) Others

Dopamine antagonists Metoclopramide (Maxeran) 10 mg po q4h Domperidone 10 mg po q4h Prochlorperazine (Stemetil) 10 mg po q4h Haldol Methotrimeprazine (Nozinan)

H1 antagonist Dimenhydrinate (Gravol) 25 50mg po q4h Promethazine (Phenergan) 25 mg po q4h

Serotonin antagonists Ondansetron (Zofran) 4 8mg po bid Granisetron (Kytril) 1 mg po bid

Antimuscarinic Scopolamine Transderm V patch q3days

Others Nabilone Dronabinol Dexamethasone Lorazepam

Chemoreceptor Trigger Zone Cerebral High CNS Benzodiazepines Nabilone, THC Relaxation Vestibular H1 Antagonist Dimenhydrinate Methotrimeprazine Anticholinergic Scopolamine Atropine Increased Intracranial Press Dexamethasone? VP Shunt G. Michael Downing Integrative Vomiting Centre (IVC) Anticholinergic Scopolamine Atropine H1 Antagonist Dimenhydrinate Cyclizine Methotrimeprazine 5HT2 Antagonist Methotrimeprazine 5HT3 Antagonist Granisetron D2 Antagonist Prochlorperazine Haloperidol Methotrimeprazine Chlorpromazine Gastrokinetics Metoclopramide Domeperidone 5HT3 Antagonist Granisetron GI Tract Vagal D2 Antagonist Gastrokinetics Metoclopramide DomeperidonePhenothiazi nes Methotrimeprazine 5HT4 Agonist Cisapride Metoclopramide 5HT3 Antagonist Granisetron Metoclopramide Octreotide Dexamethasone

Chemoreceptor Trigger Zone Cerebral High CNS Vestibular Integrative Vomiting Centre (IVC) Increased Intracranial Press G. Michael Downing GI Tract Vagal

Principles of treating nausea and vomiting Treat the cause if possible Environmental measures Antiemetic use Anticipate need if possible Aim at presumed receptor.s involved Use adequate, regular doses Combinations if necessary Anticipate need for alternate routes

Questions?